nafcillin has been researched along with Bacteremia in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 13 (52.00) | 24.3611 |
| 2020's | 6 (24.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adelnia, H; Alavi, SE; Ebrahimi Shahmabadi, H; Koohi Moftakhari Esfahani, M; Raza, A | 1 |
| Ahn, JY; Kim, HR; Kim, YC; La, YJ; Oh, DH | 1 |
| Adams, EH; Algrim, A; Cummings, C; Finch, CK; Samarin, M; Twilla, JD | 1 |
| Sarria, JC | 1 |
| Cox, HL; Donohue, LE; Eby, JC; Gandhi, AM; Shah, MD | 1 |
| Karchmer, AW | 1 |
| Jang, HC; Jung, SI; Kiem, SM; Kim, ES; Kim, HB; Kim, HI; Kim, NJ; Kim, YK; Kim, YS; Kwak, YG; Lee, S; Lee, SH; Park, KH; Park, WB; Song, KH | 1 |
| Baracco, G; Carrasquillo, M; Gauthier, TP; Lichtenberger, P | 1 |
| Choi, JY; Han, SH; Jeong, SJ; Jeong, WY; Jung, IY; Kim, EJ; Kim, J; Kim, JJ; Kim, JM; Kim, YC; Ku, NS; Lee, SJ; Oh, DH; Seong, H; Song, YG | 1 |
| Barber, GR; Barron, MA; Fish, DN; Goolsby, TA; Miller, MA; Moine, P; Mueller, SW | 1 |
| Broadbent, EK; Burrelli, CC; Gold, HS; Hirsch, EB; Mahoney, MV; Margulis, A; McCoy, C; Snyder, GM | 1 |
| Bayer, AS; Dam, Q; Dhand, A; Hensler, ME; Nizet, V; Nonejuie, P; Okumura, CY; Olson, J; Pogliano, J; Sakoulas, G; Thienphrapa, W; Yeaman, MR | 1 |
| Ellison, RT; Gandra, S; Goguen, JD; Palace, SG; Proulx, MK; Stiles, T; Torres, B; Weir, S | 1 |
| Bacchetti, P; Baxi, SM; Chambers, HF; Doernberg, SB; Pollett, S; Rutherford, GW | 1 |
| Dam, Q; Le, J; Nizet, V; Sakoulas, G; Schweizer, M; Thienphrapa, W | 1 |
| Leclair, SJ; Scarano, FJ; Tang, Y | 1 |
| Bland, CM; Bookstaver, PB; Riser, MS; Rudisill, CN | 1 |
| Choe, PG; Kim, EC; Kim, HB; Kim, NJ; Lee, S; Oh, MD; Park, SW; Park, WB; Song, KH | 1 |
| Cosgrove, SE; Furuno, JP; Harris, AD; Johnson, JK; McGregor, JC; Perencevich, EN; Sakoulas, G; Schweizer, ML; Shardell, MD; Thom, KA | 1 |
| Ali, A; Bechard, D; Jovin, IS; Kaszala, K; Khan, R; Raza, S | 1 |
| Baker, SD; Horger, DC; Keane, TE | 1 |
| Chan-Tack, KM; Johnson, JK | 1 |
| Kan, VL; Turner, TD; Zelazny, AM | 1 |
| Hoelzer, BC; Hooten, WM; Weingarten, TN; Wilson, PR; Wilson, WR; Wright, RS | 1 |
| Corey, GR; Fowler, VG; Gopal, AK; Gottlieb, G; Kong, L; Marr, KA; McClelland, RS; Sanders, LL; Sexton, DJ | 1 |
1 trial(s) available for nafcillin and Bacteremia
| Article | Year |
|---|---|
Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cefazolin; Drug Therapy, Combination; Female; Humans; Male; Methicillin; Middle Aged; Nafcillin; Prospective Studies; Republic of Korea; Staphylococcal Infections | 2018 |
24 other study(ies) available for nafcillin and Bacteremia
| Article | Year |
|---|---|
PEG-grafted liposomes for enhanced antibacterial and antibiotic activities: An in vivo study.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Liposomes; Mice; Nafcillin; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Glycopeptides; Humans; Methicillin; Nafcillin; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2022 |
Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Female; Humans; Male; Middle Aged; Nafcillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2020 |
Methicillin-Susceptible Staphylococcus Aureus Bacteremia: Cefazolin in Prime But Nafcillin Not Ready for an Exit.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Humans; Nafcillin; Staphylococcal Infections; Staphylococcus aureus | 2020 |
Tolerability of Cefazolin in Nafcillin-Intolerant Patients for the Treatment of Methicillin-Susceptible Staphylococcus aureus Infections.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Humans; Methicillin; Nafcillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2021 |
Definitive Treatment for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Data Versus a Definitive Answer?
Topics: Bacteremia; Cefazolin; Cohort Studies; Humans; Methicillin; Nafcillin; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2017 |
Economic Impact of a Preferred Anti-Methicillin Susceptible Staphylococcus aureus Protocol.
Topics: Bacteremia; Cefazolin; Cohort Studies; Humans; Methicillin; Nafcillin; Oxacillin; Staphylococcus aureus | 2018 |
Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Cohort Studies; Cross Infection; Female; Glycopeptides; Hospital Mortality; Humans; Intensive Care Units; Male; Methicillin; Middle Aged; Nafcillin; Proportional Hazards Models; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Tertiary Care Centers | 2018 |
A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cefazolin; Endocarditis; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Nafcillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vascular Grafting; Young Adult | 2020 |
Does the Beta-Lactam Matter? Nafcillin versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefazolin; Creatinine; Female; Humans; Male; Middle Aged; Nafcillin; Retrospective Studies; Severity of Illness Index; Staphylococcus aureus; Tertiary Care Centers; Treatment Outcome | 2018 |
Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteremia; Cathelicidins; Cell Line; Cells, Cultured; Daptomycin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Humans; Immunity, Innate; Keratinocytes; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Viability; Middle Aged; Nafcillin; Neutrophils; Phagocytosis; Staphylococcal Infections | 2014 |
Reversion From Methicillin Susceptibility to Methicillin Resistance in Staphylococcus aureus During Treatment of Bacteremia.
Topics: Aged; Amino Acid Sequence; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Base Sequence; DNA, Bacterial; Frameshift Mutation; Gene Expression Regulation, Bacterial; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Nafcillin; Penicillin-Binding Proteins; Prosthesis-Related Infections; Staphylococcal Infections; Vancomycin | 2016 |
Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center.
Topics: Anti-Bacterial Agents; Bacteremia; California; Cefazolin; Cross Infection; Female; Humans; Male; Methicillin; Middle Aged; Nafcillin; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Tertiary Care Centers | 2016 |
Effects of vancomycin versus nafcillin in enhancing killing of methicillin-susceptible Staphylococcus aureus causing bacteremia by human cathelicidin LL-37.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteremia; Bacteriolysis; Cathelicidins; Drug Interactions; Humans; Microbial Sensitivity Tests; Microbial Viability; Nafcillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2016 |
Septicemic arthritis with antibiotic resistance: a case study.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Arthritis, Infectious; Arthritis, Rheumatoid; Bacteremia; beta-Lactam Resistance; Cross Infection; Escherichia coli; Escherichia coli Infections; Fatal Outcome; Humans; Leukopenia; Male; Middle Aged; Nafcillin; Prednisone; Staphylococcal Infections; Vancomycin | 2008 |
Cerebrospinal fluid penetration of high-dose daptomycin in suspected Staphylococcus aureus meningitis.
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Humans; Male; Meningitis, Bacterial; Methicillin; Middle Aged; Nafcillin; Nephritis, Interstitial; Recurrence; Staphylococcal Infections; Staphylococcus aureus | 2010 |
Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?
Topics: Adult; Aged; Bacteremia; Case-Control Studies; Cefazolin; Female; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Nafcillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2011 |
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cefazolin; Cohort Studies; Female; Humans; Male; Middle Aged; Models, Statistical; Nafcillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Treatment Outcome; Vancomycin | 2011 |
Septic pulmonary embolism in a patient with defibrillator lead endocarditis.
Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Brachiocephalic Veins; Defibrillators, Implantable; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Furunculosis; Humans; Jaw; Jugular Veins; Male; Nafcillin; Pulmonary Embolism; Reoperation; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis; Warfarin | 2012 |
Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscess.
Topics: Abscess; Adult; Bacteremia; Ciprofloxacin; Combined Modality Therapy; Community-Acquired Infections; Disease Susceptibility; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Hepatitis C; Humans; Male; Methicillin Resistance; Nafcillin; Orchitis; Prostatitis; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Substance Abuse, Intravenous; Suppuration; Transurethral Resection of Prostate; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2004 |
An unusual Gram stain finding.
Topics: Anti-Bacterial Agents; Bacteremia; Enterobacter aerogenes; Enterobacteriaceae Infections; Humans; Male; Middle Aged; Nafcillin; Penicillin-Binding Proteins | 2005 |
Invasive nontypeable Haemophilus influenzae infection in an adult with laryngeal cancer.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Follow-Up Studies; Haemophilus Infections; Haemophilus influenzae; Humans; Laryngeal Neoplasms; Male; Middle Aged; Nafcillin; Treatment Outcome | 2006 |
Paraspinal abscess complicated by endocarditis following a facet joint injection.
Topics: Abscess; Aged; Analgesia, Epidural; Analgesics, Non-Narcotic; Bacteremia; Bupivacaine; Endocarditis, Bacterial; Gentamicins; Humans; Injections, Intra-Articular; Lidocaine; Low Back Pain; Lumbar Vertebrae; Male; Methicillin Resistance; Nafcillin; Polyradiculopathy; Sacrum; Staphylococcal Infections; Triamcinolone; Vancomycin; Zygapophyseal Joint | 2008 |
Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients.
Topics: Algorithms; Anti-Bacterial Agents; Bacteremia; Female; Follow-Up Studies; Guideline Adherence; Humans; Male; Middle Aged; Nafcillin; Outcome and Process Assessment, Health Care; Penicillins; Regression Analysis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1998 |